Martin Wilson - General Counsel at Rocket Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Stock Symbol
RCKT, RCKTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Martin Wilson - trading volume in the past year for Rocket Pharmaceuticals, Inc.

Holdings reported by Martin Wilson for Rocket Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 65,762 $1.54 M $23.35 May 16, 2024 Direct
Stock Option (Right to Buy) 49,091 $684 K $13.93 Feb 16, 2024 Direct Common Stock
Restricted Stock Units 19,367 $527 K $27.20 Feb 14, 2024 Direct Common Stock

Transactions reported by Martin Wilson for Rocket Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership